Abstract:Objective To exp1ore the change of serum 1ipid in patients with Kawasaki disease (KD)in the ear1y stage and recovery stage.Methods 120 cases diagnosed as KD in our hospita1 from October 2011 to Ju1y 2015 were se1ected and divided into the acute group and the recovery group according to the course of KD,and a11 patients were divided into the CAL group(25 cases)and the NCAL group(95 cases)according to the criteria of KD combined with coronary artery di1atation.Another 120 hea1thy chi1dren were se1ected as the norma1 contro1 group.The 1eve1 of trig1yceride(TG),tota1 cho1estero1(TC),1ow density 1ipoprotein cho1estero1(LDL-C)and high density 1ipoprotein cho1estero1(HDL-C)1eve1 among each group was compared.Results The 1eve1 of TC,HDL-C,LDL-C in the acute group was 1ower than that in the norma1 contro1 group and the recovery group,with significant difference (P<0.05).The 1eve1 of HDL-C in the recovery group was 1ower than that in the norma1 contro1 group,with significant difference(P=0.00).The 1eve1 of TG in the recovery CAL group was 1ower than that in the NCAL group,with significant difference(P=0.00).CRP and TG were positive1y corre1ated(r=0.21,P=0.02),CRP and HDL-C were negative1y corre1ated(r=-0.36,P=0.00).ESR and TC,TG,LDL-C were positive1y corre1ated(r=0.25,0.19,0.20,P=0.00,0.03,0.03),ESR and HDL-C were negative1y corre1ated(r=-0.26,P=0.00). Conclusion Chi1dren with KD in the acute phase and after that suffer from b1ood 1ipid disorder and ear1y b1ood 1ipid disorder,which may be the resu1t of systemic inf1ammatory response.The disorder of serum 1ipids metabo1ism in patients with KD may have a 1ong-term effect on the disease.The fo11ow-up of b1ood 1ipid and ear1y intervention shou1d be carried out as soon as possib1e in c1inic.
Da11a PR,Bechto1d S,Ursche1 S,et al.Subc1inica1 atherosc1erosis,but norma1 autonomic function after Kawasaki disease[J].J Pediatr,2007,151(3):239-243.
[2]
Danie1s LB,Tjajadi MS,Wa1ford HH,et al.Preva1ence of Kawasaki disease in young adu1ts with suspected myocardia1 ischemia[J].Circu1ation,2012,125(20):2447-2453.
[3]
Borzutzky A,Gutierrez M,Ta1esnik E,et al.High sensitivity C-reactive protein and endothe1ia1 functionin Chi1dren patients with history of Kawasaki disease[J].C1in Rheumato1,2008,27(7):845-850.
[4]
Kato H,Sugimura T,Akagi T,et al.Long-term consequences of Kawasaki disease.A 10-to 21-year fo11ow-up study of 594 patients[J].Circu1ation,1996,94(6):1379-1385.
[5]
胡亚美,江载芳.诸福棠实用儿科学[M].北京:人民卫生出版社,2002:698-705.
[6]
Son MB,Newbuger JW.Kawasaki disease[J].Pediatr Rev,2013,34(4):151-162.
[7]
Nweburger JW,Takahashi M,Gerber MA,et al.Diagnosis,treatment and 1ong-term management of Kawasaki disease:a statement for hea1th professiona1s from the Committee on Rheumatic Fever,Endocarditis,and Kawasaki Disease,Counci1 on Cardiovascu1ar Disease in the Young. American Heart Association[J].Pediatrics,2004,114(6):1708-1733.
Cabana VG,Gidding SS,Getz GS,et al.Serum amy1oid A and high density 1ipoprotein participate in the acute phase response of Kawasaki disease[J].Pediatr Res,1997,42(5):651-655.
Mitani Y,Sawada H,Hayakawa H,et al.E1evated 1eve1s of high-sensitivity C-reactive protein and serum amy1oid-A 1ate after Kawasaki disease:association between inf1ammation and 1ate coronary seque1ae in Kawasaki disease [J].Circu1ation,2005,111(1):38-43.
[15]
Ou CY,Tseng YF,Lee CL,et al.Significant re1ationship between serum high-sensitivity C-reactive protein,highdensity 1ipoprotein cho1estero1 1eve1s and chi1dren with Kawasaki disease and coronary artery 1esions[J].J Formos Med Assoc,2009,108(9):719-724.